» Authors » Unurzul Jigmeddagva

Unurzul Jigmeddagva

Explore the profile of Unurzul Jigmeddagva including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 147
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Li L, Matsui Y, Prahl M, Cassidy A, Golan Y, Jigmeddagva U, et al.
NPJ Vaccines . 2024 Aug; 9(1):156. PMID: 39191763
Hybrid immunity against SARS-CoV-2 has not been well studied in pregnancy. We conducted a comprehensive analysis of neutralizing antibodies (nAb) and binding antibodies in pregnant individuals who received mRNA vaccination,...
2.
Chen H, Kapidzic M, Gantar D, Aksel S, Levan J, Abrahamsson D, et al.
Toxicol Sci . 2023 Sep; 196(2):187-199. PMID: 37738295
Poly- and perfluroroalkylated substances (PFAS) are a major class of surfactants used in industry applications and consumer products. Despite efforts to reduce the usage of PFAS due to their environmental...
3.
Golan Y, Ilala M, Li L, Gay C, Hunagund S, Lin C, et al.
iScience . 2023 Sep; 26(10):107767. PMID: 37731614
Little is known about the persistence of human milk anti-SARS-CoV-2 antibodies after 2 and 3 vaccine doses and infection following 3 dose. In this study, human milk, saliva, and blood...
4.
Cassidy A, Li L, Golan Y, Gay C, Lin C, Jigmeddagva U, et al.
JAMA Netw Open . 2023 Jul; 6(7):e2323405. PMID: 37450302
Importance: Longitudinal data on COVID-19 messenger RNA (mRNA) vaccine reactogenicity and immunogenicity in pregnancy and for the mother-infant dyad are needed. Objective: To examine COVID-19 mRNA vaccine reactogenicity and immunogenicity...
5.
Golan Y, Ilala M, Gay C, Hunagund S, Lin C, Cassidy A, et al.
medRxiv . 2022 Dec; PMID: 36561188
Anti-SARS-CoV-2 antibodies have been found in human-milk after COVID-19 infection and vaccination. However, little is known about their persistence in milk after booster vaccination and breakthrough infection. In this study,...
6.
Prahl M, Golan Y, Cassidy A, Matsui Y, Li L, Alvarenga B, et al.
Nat Commun . 2022 Jul; 13(1):4422. PMID: 35908075
Studies are needed to evaluate the safety and effectiveness of mRNA SARS-CoV-2 vaccination during pregnancy, and the levels of protection provided to their newborns through placental transfer of antibodies. Here,...
7.
Matsui Y, Li L, Prahl M, Cassidy A, Ozarslan N, Golan Y, et al.
JCI Insight . 2022 May; 7(12). PMID: 35579965
Pregnancy confers unique immune responses to infection and vaccination across gestation. To date, there are limited data comparing vaccine- and infection-induced neutralizing Abs (nAbs) against COVID-19 variants in mothers during...
8.
Prahl M, Golan Y, Cassidy A, Matsui Y, Li L, Alvarenga B, et al.
medRxiv . 2021 Dec; PMID: 34931197
Studies are needed to evaluate the safety and effectiveness of mRNA SARS-CoV-2 vaccination during pregnancy, and the levels of protection provided to their newborns through placental transfer of antibodies. We...
9.
Prahl M, Golan Y, Cassidy A, Matsui Y, Li L, Alvarenga B, et al.
Res Sq . 2021 Dec; PMID: 34931183
Studies are needed to evaluate the safety and effectiveness of mRNA SARS-CoV-2 vaccination during pregnancy, and the levels of protection provided to their newborns through placental transfer of antibodies. We...
10.
Golan Y, Prahl M, Cassidy A, Gay C, Wu A, Jigmeddagva U, et al.
Front Immunol . 2021 Nov; 12:777103. PMID: 34804068
Background: Data regarding symptoms in the lactating mother-infant dyad and their immune response to COVID-19 mRNA vaccination during lactation are needed to inform vaccination guidelines. Methods: From a prospective cohort...